Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David C Wilson
Safety and Efficacy of A-101 Hydrogen Peroxide Topical Solution in Adults With Seborrheic Keratosis: Results From the Phase 3, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study
SKIN The Journal of Cutaneous Medicine
Antioxidants Increase in Time in VLBW Infants Who Develop BPD: Possible Role of Postnatal Corticosteriods † 1588
Pediatric Research
Child Health
Pediatrics
Perinatology
Related publications
Safety and Efficacy of Hydrogen Peroxide Topical Solution, 40% (W/W) in Patients With Seborrheic Keratoses: Results From Two Identical, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies (A-101-Sebk-301/302)
Journal of the American Academy of Dermatology
Dermatology
Efficacy and Safety of AR101 in Peanut Allergy: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Protocol of a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre Study of the Efficacy and Safety of Nicotinamide in Patients With Friedreich Ataxia (NICOFA)
Neurological Research and Practice
Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study
SKIN The Journal of Cutaneous Medicine
Efficacy, Safety, and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis: A Randomized, Double-Blind Phase 3 Study, MEASURE 3
Arthritis Research & Therapy
A Topical Microemulsion for the Prevention of Allergic Rhinitis Symptoms: Results of a Randomized, Controlled, Double-Blind, Parallel Group, Multicentre, Multinational Clinical Trial (Nares Study)
Allergy, Asthma and Clinical Immunology
Immunology
Pulmonary
Allergy
Respiratory Medicine
Prevalence of Comorbidities With Peanut Allergy: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Clinical Efficacy and Safety of Dotinurad, a Novel Selective Urate Reabsorption Inhibitor, in Japanese Hyperuricemic Patients With or Without Gout: Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Confirmatory Phase 2 Study
Clinical and Experimental Nephrology
Physiology
Nephrology
Long-Term Efficacy and Safety of Brodalumab in the Treatment of Psoriasis: 120-Week Results From the Randomized, Double-Blind, Placebo- And Active Comparator–controlled Phase 3 AMAGINE-2 Trial
Journal of the American Academy of Dermatology
Dermatology
